Alvarez-Moreno, C.

P247

Int. J. Antimicrob. Agents. 2022.

Head-to-head comparison of CLSI, EUCAST, Etest and Vitek2 results for Candida auris susceptibility testing.

https://doi.org/10.1016/j.ijantimicag.2022.106558

P245

J. Antimicrob. Chemother. 2022, 77, 585–597.

Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata.

https://doi.org/10.1093/jac/dkab454

P229

J. Fungi. 2020, 6, 235.

A one health perspective to recognize Fusarium as important in clinical practice.

doi: 10.3390/jof6040235

P228

Clin. Infect. Dis. 2020, ciaa1595.

Candida auris: a latent threat to critically ill patients with COVID-19.

doi: 10.1093/cid/ciaa1595

P187

Mycologia 2019, 111, 217-224.

Fungicide-driven alterations in azole-resistant Aspergillus fumigatus are related to vegetable crops in Colombia, South America.

doi: 10.1080/00275514.2018.1557796

P171

Int. J. Infect. Dis. 2018, 69, 63-67.

First report of sporadic cases of Candida auris in Colombia.

doi: 10.1016/j.ijid.2018.01.034.

P160

Sci. Rep. 2017, 7, 45631;

Azole-resistant Aspergillus fumigatus harboring TR34/L98H, TR46/Y121F/T289A and TR53 mutations related to flower fields in Colombia.

doi: 10.1038/srep45631.

P150

Emerg. Infect. Dis. 2016, 22, 156-157.

Multiple Fungicide-Driven Alterations in Azole-Resistant Aspergillus fumigatus, Colombia, 2015.

Le Pape, P. | Lavergne, R.-A. | Morio, F. | Alvarez-Moreno, C.

doi: 10.3201/eid2201.150978.